Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Hospices Civils de Lyon: Clinical Trials & FDA Approval Profile

Hospices Civils de Lyon (Global / Institutional) sponsors 54 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 24 active protocols (13 recruiting now), 15 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)16.7%
Median Closed Enrollment vs National (145 pts)49 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Hospices Civils de Lyon
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)54
Active Pipeline (Recruiting Now)24 (13)
Completed vs Stopped Early15 / 9 (16.7%)
Median Closed Actual Enrollment49 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Hospices Civils de Lyon
Hospital Research SiteLocationShared Protocols
Centre Hospitalier Lyon SudPierre-Bénite6
Centre Oscar LambretLille, Hauts-de-France3
Centre Léon BérardLyon3

Explore interactive annual charts and M&A subsidiary rollups in the Hospices Civils de Lyon Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI